By Matt Jones

NEW YORK (GenomeWeb News) – A US Department of Health and Human Services committee said in a new report that steps should be taken to help the US healthcare system prepare for the arrival of widespread clinical genome-based medicine, including addressing a lack of knowledge among doctors, public health professionals, and patients.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has approved Kite Pharmaceuticals' CAR T-cell therapy for large B-cell lymphomas, the New York Times reports.

Kaiser Health News reports that gene therapies could cost more than a million dollars.

Worcester Polytechnic Institute researchers have received a grant to combine biology and computer science for high school students.

In Nature this week: variants associated with obsessive-compulsive disorder, review of key CRISPR enzymes, and more.